title: [Efficacy of cytoflavin in the treatment of chronic cerebral ischemia].
abstract: The author presents results of multicentre randomized studies of therapeutic efficiency of cytoflavin tablets in patients with chronic cerebral ischemia including asthenovegetative syndrome. Cytoflavin was shown to reduce clinical manifestations of asthenia, anxiety, depression, cognitive and emotional disorders and simultaneously improve quality of life. The efficiency of cytoflavin is confirmed by improved physical and psychic state of the patients, their enhanced social activity.
authors.forename: Z A
authors.initials: ZA
authors.lastname: Suslina
authors.forename: E G
authors.initials: EG
authors.lastname: Klocheva
authors.forename: M A
authors.initials: MA
authors.lastname: Piradov
authors.forename: S A
authors.initials: SA
authors.lastname: Rumiantseva
authors.forename: M G
authors.initials: MG
authors.lastname: Romantsov
authors.forename: A L
authors.initials: AL
authors.lastname: Kovalenko
mesh_terms: D001247:Asthenia / Q000188:drug therapy / Q000523:psychology; D002545:Brain Ischemia / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology; D002908:Chronic Disease; D004338:Drug Combinations; D005486:Flavin Mononucleotide / Q000627:therapeutic use*; D006801:Humans; D007290:Inosine Diphosphate / Q000627:therapeutic use*; D015337:Multicenter Studies as Topic; D009483:Neuropsychological Tests; D009536:Niacinamide / Q000627:therapeutic use*; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D013386:Succinates / Q000627:therapeutic use*
chemical_list: D004338:Drug Combinations; D013386:Succinates; C507879:cytoflavin; D009536:Niacinamide; D005486:Flavin Mononucleotide; D007290:Inosine Diphosphate